Dr. Mariangela Canaan, MD

Dr. Canaan practices at AdventHealth Home Infusion Central Florida in Longwood, Florida.

Dr. Canaan's NPI, 1689876344, was assigned on June 4, 2007. Dr. Canaan holds Florida license ME 103159.

Dr. Canaan's primary practice is AdventHealth Home Infusion Central Florida, at 556 Florida Central Pkwy, Longwood, FL 32750 in Seminole County. The practice phone is (407) 660-1122.

Dr. Canaan's primary practice is AdventHealth Home Infusion Central Florida in Longwood, Florida. Dr. Canaan is also affiliated with HCA Florida Lake Monroe Hospital. The medical group on file is Premier Infectious Disease Care. Dmand AI also links Dr. Canaan to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Canaan practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Canaan's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Canaan is licensed in Florida.

CMS data shows 976 Medicare services from Dr. Canaan across 4 procedure codes in 2024, for 216 Medicare patients. Medicare paid $77,968 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 216 Medicare patients who saw Dr. Canaan in 2024. The largest group is 75 to 84, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Canaan's median patient age at 61, with 52% women.

In 2024, Dr. Canaan wrote 95 Medicare Part D claims for 31 patients. 98% of them were for generic drugs. CMS names the drug for 53 of them, across 4 drugs with 11 or more claims each, at $12,836 in total drug cost. In 2023, CMS named 58 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 72 out of 100 for Dr. Canaan for performance year 2024, reported as part of a group. Dr. Canaan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 289 general payments to Dr. Canaan from 16 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 97% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,165.